Lyndal Hesterberg's most recent trade in Oncocyte Corporation was a trade of 6,603 Common Stock done . Disclosure was reported to the exchange on Dec. 11, 2020.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Oncocyte Corporation | Lyndal Hesterberg | CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Dec 2020 | 6,603 | 7,477 (0%) | 0% | - | Common Stock |